FDA approves test to help screen for risk of opioid use disorder

The U.S. FDA approved a novel tool that uses genetic testing to help assess whether certain people are at risk of developing opioid use disorder.

Related Keywords

United States ,Katherine Keyes ,Autogenomics Avert ,Andrew Saxon ,Jeff Shuren ,Deidre Mcphillips ,Drug Administration ,Cnn ,University Of Washington School Medicine ,Columbia University Mailman School Of Public Health ,Radiological Health ,Human Services ,Us Centers For Disease ,Us Department Of Health ,Autogenomics Avertd ,Washington School ,Columbia University Mailman School ,Public Health ,Disease Control ,